Lv22
126 积分 2023-09-27 加入
Late Recurrence of Completely Resected Stage I-IIIA Lung Adenocarcinoma
2小时前
待确认
PI3K/AKT/mTOR inhibitors for hormone receptor-positive advanced breast cancer
22小时前
已完结
Tailoring Treatment to Cancer Risk and Patient Preference: The 2025 St Gallen International Breast Cancer Consensus Statement on Individualizing Therapy for Patients With Early Breast Cancer
4天前
已完结
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach
14天前
已完结
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial
15天前
已完结
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
15天前
已完结
Prognostic significance of early on-treatment evolution of circulating tumor DNA in advanced ER+/HER2- breast cancer
26天前
已完结
The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer
1个月前
已完结
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
1个月前
已完结
In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistochemistry
1个月前
已完结
皖公网安备34019202002308
